Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe OTC Drug Market Report 2017

  • QYR1029713
  • 118 Pages
  • March 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of OTC Drug

Revenue, means the sales value of OTC Drug

This report studies sales (consumption) of OTC Drug in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Bayer HealthCare

GlaxoSmithKline (GSK)

Johnson&Johnson

Pfizer

Sanofi

AstraZeneca

BioGaia

Bristol Myers Squibb

Bukwang Pharmaceutica

Chr. Hansen

Cipla

CoLucid

Daiichi Sankyo

Friggs

DSM

Eisai

Eli Lilly

Herbalife

Euradite

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of OTC Drug in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Split by application, this report focuses on sales, market share and growth rate of OTC Drug in each application, can be divided into

Application 1

Application 2

Table of Contents

Europe OTC Drug Market Report 2017

1 OTC Drug Overview

1.1 Product Overview and Scope of OTC Drug

1.2 Classification of OTC Drug

1.2.1 Type I

1.2.2 Type II

1.3 Application of OTC Drug

1.3.1 Application 1

1.3.2 Application 2

1.4 OTC Drug Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of OTC Drug (2012-2022)

1.5.1 Europe OTC Drug Sales and Growth Rate (2012-2022)

1.5.2 Europe OTC Drug Revenue and Growth Rate (2012-2022)

2 Europe OTC Drug by Manufacturers, Type and Application

2.1 Europe OTC Drug Market Competition by Manufacturers

2.1.1 Europe OTC Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe OTC Drug Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe OTC Drug (Volume and Value) by Type

2.2.1 Europe OTC Drug Sales and Market Share by Type (2012-2017)

2.2.2 Europe OTC Drug Revenue and Market Share by Type (2012-2017)

2.3 Europe OTC Drug (Volume and Value) by Countries

2.3.1 Europe OTC Drug Sales and Market Share by Countries (2012-2017)

2.3.2 Europe OTC Drug Revenue and Market Share by Countries (2012-2017)

2.4 Europe OTC Drug (Volume) by Application

3 Germany OTC Drug (Volume, Value and Sales Price)

3.1 Germany OTC Drug Sales and Value (2012-2017)

3.1.1 Germany OTC Drug Sales and Growth Rate (2012-2017)

3.1.2 Germany OTC Drug Revenue and Growth Rate (2012-2017)

3.1.3 Germany OTC Drug Sales Price Trend (2012-2017)

3.2 Germany OTC Drug Sales and Market Share by Manufacturers

3.3 Germany OTC Drug Sales and Market Share by Type

3.4 Germany OTC Drug Sales and Market Share by Application

4 France OTC Drug (Volume, Value and Sales Price)

4.1 France OTC Drug Sales and Value (2012-2017)

4.1.1 France OTC Drug Sales and Growth Rate (2012-2017)

4.1.2 France OTC Drug Revenue and Growth Rate (2012-2017)

4.1.4 France OTC Drug Sales Price Trend (2012-2017)

4.2 France OTC Drug Sales and Market Share by Manufacturers

4.3 France OTC Drug Sales and Market Share by Type

4.4 France OTC Drug Sales and Market Share by Application

5 UK OTC Drug (Volume, Value and Sales Price)

5.1 UK OTC Drug Sales and Value (2012-2017)

5.1.1 UK OTC Drug Sales and Growth Rate (2012-2017)

5.1.2 UK OTC Drug Revenue and Growth Rate (2012-2017)

5.1.5 UK OTC Drug Sales Price Trend (2012-2017)

5.2 UK OTC Drug Sales and Market Share by Manufacturers

5.3 UK OTC Drug Sales and Market Share by Type

5.4 UK OTC Drug Sales and Market Share by Application

6 Russia OTC Drug (Volume, Value and Sales Price)

6.1 Russia OTC Drug Sales and Value (2012-2017)

6.1.1 Russia OTC Drug Sales and Growth Rate (2012-2017)

6.1.2 Russia OTC Drug Revenue and Growth Rate (2012-2017)

6.1.6 Russia OTC Drug Sales Price Trend (2012-2017)

6.2 Russia OTC Drug Sales and Market Share by Manufacturers

6.3 Russia OTC Drug Sales and Market Share by Type

6.4 Russia OTC Drug Sales and Market Share by Application

7 Italy OTC Drug (Volume, Value and Sales Price)

7.1 Italy OTC Drug Sales and Value (2012-2017)

7.1.1 Italy OTC Drug Sales and Growth Rate (2012-2017)

7.1.2 Italy OTC Drug Revenue and Growth Rate (2012-2017)

7.1.7 Italy OTC Drug Sales Price Trend (2012-2017)

7.2 Italy OTC Drug Sales and Market Share by Manufacturers

7.3 Italy OTC Drug Sales and Market Share by Type

7.4 Italy OTC Drug Sales and Market Share by Application

8 Spain OTC Drug (Volume, Value and Sales Price)

8.1 Spain OTC Drug Sales and Value (2012-2017)

8.1.1 Spain OTC Drug Sales and Growth Rate (2012-2017)

8.1.2 Spain OTC Drug Revenue and Growth Rate (2012-2017)

8.1.8 Spain OTC Drug Sales Price Trend (2012-2017)

8.2 Spain OTC Drug Sales and Market Share by Manufacturers

8.3 Spain OTC Drug Sales and Market Share by Type

8.4 Spain OTC Drug Sales and Market Share by Application

9 Benelux OTC Drug (Volume, Value and Sales Price)

9.1 Benelux OTC Drug Sales and Value (2012-2017)

9.1.1 Benelux OTC Drug Sales and Growth Rate (2012-2017)

9.1.2 Benelux OTC Drug Revenue and Growth Rate (2012-2017)

9.1.9 Benelux OTC Drug Sales Price Trend (2012-2017)

9.2 Benelux OTC Drug Sales and Market Share by Manufacturers

9.3 Benelux OTC Drug Sales and Market Share by Type

9.4 Benelux OTC Drug Sales and Market Share by Application

10 Europe OTC Drug Manufacturers Analysis

10.1 Bayer HealthCare

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 OTC Drug Product Type, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 GlaxoSmithKline (GSK)

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 OTC Drug Product Type, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Johnson&Johnson

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 OTC Drug Product Type, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Pfizer

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 OTC Drug Product Type, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Sanofi

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 OTC Drug Product Type, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 AstraZeneca

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 OTC Drug Product Type, Application and Specification

10.6.2.1 Product A

10.6.2.2 Product B

10.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 BioGaia

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 OTC Drug Product Type, Application and Specification

10.7.2.1 Product A

10.7.2.2 Product B

10.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Bristol Myers Squibb

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 OTC Drug Product Type, Application and Specification

10.8.2.1 Product A

10.8.2.2 Product B

10.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 Bukwang Pharmaceutica

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 OTC Drug Product Type, Application and Specification

10.9.2.1 Product A

10.9.2.2 Product B

10.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Chr. Hansen

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 OTC Drug Product Type, Application and Specification

10.10.2.1 Product A

10.10.2.2 Product B

10.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 Cipla

10.12 CoLucid

10.13 Daiichi Sankyo

10.14 Friggs

10.15 DSM

10.16 Eisai

10.17 Eli Lilly

10.18 Herbalife

10.19 Euradite

11 OTC Drug Manufacturing Cost Analysis

11.1 OTC Drug Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of OTC Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 OTC Drug Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe OTC Drug Market Forecast (2017-2022)

14.1 Germany OTC Drug Sales Forecast (2017-2022)

14.2 France OTC Drug Sales Forecast (2017-2022)

14.3 UK OTC Drug Sales Forecast (2017-2022)

14.4 Russia OTC Drug Sales Forecast (2017-2022)

14.5 Italy OTC Drug Sales Forecast (2017-2022)

14.6 Spain OTC Drug Sales Forecast (2017-2022)

14.7 Benelux OTC Drug Sales Forecast (2017-2022)

14.8 Europe OTC Drug Sales Forecast by Type (2017-2022)

14.9 Europe OTC Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of OTC Drug

Table Classification of OTC Drug

Figure Europe Sales Market Share of OTC Drug by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of OTC Drug

Figure Europe Sales Market Share of OTC Drug by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany OTC Drug Revenue and Growth Rate (2012-2022)

Figure France OTC Drug Revenue and Growth Rate (2012-2022)

Figure UK OTC Drug Revenue and Growth Rate (2012-2022)

Figure Russia OTC Drug Revenue and Growth Rate (2012-2022)

Figure Italy OTC Drug Revenue and Growth Rate (2012-2022)

Figure Spain OTC Drug Revenue and Growth Rate (2012-2022)

Figure Benelux OTC Drug Revenue and Growth Rate (2012-2022)

Figure Europe OTC Drug Sales and Growth Rate (2012-2022)

Figure Europe OTC Drug Revenue and Growth Rate (2012-2022)

Table Europe OTC Drug Sales of Key Manufacturers (2015 and 2016)

Table Europe OTC Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 OTC Drug Sales Share by Manufacturers

Figure 2016 OTC Drug Sales Share by Manufacturers

Table Europe OTC Drug Revenue by Manufacturers (2015 and 2016)

Table Europe OTC Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe OTC Drug Revenue Share by Manufacturers

Table 2016 Europe OTC Drug Revenue Share by Manufacturers

Table Europe OTC Drug Sales and Market Share by Type (2012-2017)

Table Europe OTC Drug Sales Share by Type (2012-2017)

Figure Sales Market Share of OTC Drug by Type (2012-2017)

Figure Europe OTC Drug Sales Growth Rate by Type (2012-2017)

Table Europe OTC Drug Revenue and Market Share by Type (2012-2017)

Table Europe OTC Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of OTC Drug by Type (2012-2017)

Figure Europe OTC Drug Revenue Growth Rate by Type (2012-2017)

Table Europe OTC Drug Sales and Market Share by Countries (2012-2017)

Table Europe OTC Drug Sales Share by Countries (2012-2017)

Figure Sales Market Share of OTC Drug by Countries (2012-2017)

Table Europe OTC Drug Revenue and Market Share by Countries (2012-2017)

Table Europe OTC Drug Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of OTC Drug by Countries (2012-2017)

Table Europe OTC Drug Sales and Market Share by Application (2012-2017)

Table Europe OTC Drug Sales Share by Application (2012-2017)

Figure Sales Market Share of OTC Drug by Application (2012-2017)

Figure Germany OTC Drug Sales and Growth Rate (2012-2017)

Figure Germany OTC Drug Revenue and Growth Rate (2012-2017)

Figure Germany OTC Drug Sales Price Trend (2012-2017)

Table Germany OTC Drug Sales by Manufacturers (2015 and 2016)

Table Germany OTC Drug Market Share by Manufacturers (2015 and 2016)

Table Germany OTC Drug Sales by Type (2015 and 2016)

Table Germany OTC Drug Market Share by Type (2015 and 2016)

Table Germany OTC Drug Sales by Application (2015 and 2016)

Table Germany OTC Drug Market Share by Application (2015 and 2016)

Figure France OTC Drug Sales and Growth Rate (2012-2017)

Figure France OTC Drug Revenue and Growth Rate (2012-2017)

Figure France OTC Drug Sales Price Trend (2012-2017)

Table France OTC Drug Sales by Manufacturers (2015 and 2016)

Table France OTC Drug Market Share by Manufacturers (2015 and 2016)

Table France OTC Drug Sales by Type (2015 and 2016)

Table France OTC Drug Market Share by Type (2015 and 2016)

Table France OTC Drug Sales by Application (2015 and 2016)

Table France OTC Drug Market Share by Application (2015 and 2016)

Figure UK OTC Drug Sales and Growth Rate (2012-2017)

Figure UK OTC Drug Revenue and Growth Rate (2012-2017)

Figure UK OTC Drug Sales Price Trend (2012-2017)

Table UK OTC Drug Sales by Manufacturers (2015 and 2016)

Table UK OTC Drug Market Share by Manufacturers (2015 and 2016)

Table UK OTC Drug Sales by Type (2015 and 2016)

Table UK OTC Drug Market Share by Type (2015 and 2016)

Table UK OTC Drug Sales by Application (2015 and 2016)

Table UK OTC Drug Market Share by Application (2015 and 2016)

Figure Russia OTC Drug Sales and Growth Rate (2012-2017)

Figure Russia OTC Drug Revenue and Growth Rate (2012-2017)

Figure Russia OTC Drug Sales Price Trend (2012-2017)

Table Russia OTC Drug Sales by Manufacturers (2015 and 2016)

Table Russia OTC Drug Market Share by Manufacturers (2015 and 2016)

Table Russia OTC Drug Sales by Type (2015 and 2016)

Table Russia OTC Drug Market Share by Type (2015 and 2016)

Table Russia OTC Drug Sales by Application (2015 and 2016)

Table Russia OTC Drug Market Share by Application (2015 and 2016)

Figure Italy OTC Drug Sales and Growth Rate (2012-2017)

Figure Italy OTC Drug Revenue and Growth Rate (2012-2017)

Figure Italy OTC Drug Sales Price Trend (2012-2017)

Table Italy OTC Drug Sales by Manufacturers (2015 and 2016)

Table Italy OTC Drug Market Share by Manufacturers (2015 and 2016)

Table Italy OTC Drug Sales by Type (2015 and 2016)

Table Italy OTC Drug Market Share by Type (2015 and 2016)

Table Italy OTC Drug Sales by Application (2015 and 2016)

Table Italy OTC Drug Market Share by Application (2015 and 2016)

Figure Spain OTC Drug Sales and Growth Rate (2012-2017)

Figure Spain OTC Drug Revenue and Growth Rate (2012-2017)

Figure Spain OTC Drug Sales Price Trend (2012-2017)

Table Spain OTC Drug Sales by Manufacturers (2015 and 2016)

Table Spain OTC Drug Market Share by Manufacturers (2015 and 2016)

Table Spain OTC Drug Sales by Type (2015 and 2016)

Table Spain OTC Drug Market Share by Type (2015 and 2016)

Table Spain OTC Drug Sales by Application (2015 and 2016)

Table Spain OTC Drug Market Share by Application (2015 and 2016)

Figure Benelux OTC Drug Sales and Growth Rate (2012-2017)

Figure Benelux OTC Drug Revenue and Growth Rate (2012-2017)

Figure Benelux OTC Drug Sales Price Trend (2012-2017)

Table Benelux OTC Drug Sales by Manufacturers (2015 and 2016)

Table Benelux OTC Drug Market Share by Manufacturers (2015 and 2016)

Table Benelux OTC Drug Sales by Type (2015 and 2016)

Table Benelux OTC Drug Market Share by Type (2015 and 2016)

Table Benelux OTC Drug Sales by Application (2015 and 2016)

Table Benelux OTC Drug Market Share by Application (2015 and 2016)

Table OTC Drug Basic Information List

Table Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Bayer HealthCare OTC Drug Sales Market Share (2012-2017)

Table GlaxoSmithKline (GSK) Basic Information List

Table GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table GlaxoSmithKline (GSK) OTC Drug Sales Market Share (2012-2017)

Table Johnson&Johnson Basic Information List

Table Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Johnson&Johnson OTC Drug Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer OTC Drug Sales Market Share (2012-2017)

Table Sanofi Basic Information List

Table Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sanofi OTC Drug Sales Market Share (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table AstraZeneca OTC Drug Sales Market Share (2012-2017)

Table BioGaia Basic Information List

Table BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table BioGaia OTC Drug Sales Market Share (2012-2017)

Table Bristol Myers Squibb Basic Information List

Table Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bristol Myers Squibb OTC Drug Sales Market Share (2012-2017)

Table Bukwang Pharmaceutica Basic Information List

Table Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bukwang Pharmaceutica OTC Drug Sales Market Share (2012-2017)

Table Chr. Hansen Basic Information List

Table Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Chr. Hansen OTC Drug Sales Market Share (2012-2017)

Table Cipla Basic Information List

Table CoLucid Basic Information List

Table Daiichi Sankyo Basic Information List

Table Friggs Basic Information List

Table DSM Basic Information List

Table Eisai Basic Information List

Table Eli Lilly Basic Information List

Table Herbalife Basic Information List

Table Euradite Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of OTC Drug

Figure Manufacturing Process Analysis of OTC Drug

Figure OTC Drug Industrial Chain Analysis

Table Raw Materials Sources of OTC Drug Major Manufacturers in 2015

Table Major Buyers of OTC Drug

Table Distributors/Traders List

Figure Germany OTC Drug Sales and Growth Rate Forecast (2017-2022)

Figure Germany OTC Drug Revenue and Growth Rate Forecast (2017-2022)

Figure France OTC Drug Sales and Growth Rate Forecast (2017-2022)

Figure France OTC Drug Revenue and Growth Rate Forecast (2017-2022)

Figure UK OTC Drug Sales and Growth Rate Forecast (2017-2022)

Figure UK OTC Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Russia OTC Drug Sales and Growth Rate Forecast (2017-2022)

Figure Russia OTC Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Italy OTC Drug Sales and Growth Rate Forecast (2017-2022)

Figure Italy OTC Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Spain OTC Drug Sales and Growth Rate Forecast (2017-2022)

Figure Spain OTC Drug Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux OTC Drug Sales and Growth Rate Forecast (2017-2022)

Figure Benelux OTC Drug Revenue and Growth Rate Forecast (2017-2022)

Table Europe OTC Drug Sales Forecast by Type (2017-2022)

Table Europe OTC Drug Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370